Beyond that, it also improves glycemic control in type 2 diabetes and assists in weight loss, indirectly reducing the risk of obesity-related complications like heart disease, stroke, and certain cancers [7]
Genetic Predispositions and Personalized Risk Assessment Emerging evidence suggests that variants in GLP1R (rs6923761) and FTO (rs9939609) genes may correlate with individual differences in GLP-1 side-effect severity and tolerability profiles
189 Subsequently, tirzepatide has been extensively investigated in the SURPASS program, a comprehensive development initiative targeting T2DM that is inadequately controlled by various glucose-lowering regimens, including lifestyle alone (SURPASS-1), 190 metformin monotherapy (SURPASS-2), 191 metformin with or without sodium-glucose co-transporter 2 inhibitors (SGLT2i) (SURPASS-3), 192 combination therapy including metformin, SGLT2i, and sulfonylureas (SURPASS-4), 193 insulin glargine with or without metformin (SURPASS-5), 88 and insulin lispro with basal insulin (SURPASS-6)
Hexavalent chromium exposure induces intestinal barrier damage via activation of the NF-kappaB signaling pathway and NLRP3 inflammasome in ducks
You want to start GLP-1 treatment within the next few days rather than waiting for a new patient appointment to open in a One Medical provider's schedule